CompletedPHASE1, PHASE2NCT00624728
Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
Studying High-grade astrocytoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Bordeaux
- Principal Investigator
- Fernandez Philippe, DrUniversity Hospital, Bordeaux, France
- Intervention
- 18F Fluorothymidine PET CT(radiation)
- Enrollment
- 21 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2008 – 2011
Study locations (2)
- Hôpital St André, CHU de Bordeaux, Bordeaux, France
- Hôpital Pellegrin-tripode , CHU de Bordeaux, Bordeaux, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00624728 on ClinicalTrials.govOther trials for High-grade astrocytoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07551336Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade GliomaBeijing Biotech
- RECRUITINGNCT06214689IDH1 and OCT4 in High Grade AstrocytomaAssiut University
- RECRUITINGNANCT05979064Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)Northwell Health
- RECRUITINGPHASE2NCT05683808Venous Thromboembolism Prevention in Outpatients With GliomaUniversity of Vermont Medical Center